Skip to main content
Premium Trial:

Request an Annual Quote

Sell, Sell, Sell

Too many in the scientific community, particularly those who control the funding, regard the commercialization of science as something "dirty," says the University of Leeds' Deputy Vice-Chancellor John Fisher in New Scientist. They say "that inspiration alone should be the driving force behind scientific labor," but this is just a "myth," Fisher says. Using the semiconductor industry as an example, he adds that some research can only be done with commercial success in mind. In the West, funders tend to lean heavily toward researchers doing discovery-led work, while research coming out of China and India is focused on economic growth.

"The ongoing battle between bottom-up research and the bottom line is seen all too clearly across the scientific spectrum," Fisher says. "It all comes down to idealism versus pragmatism. The simple truth is that without commercial success, societal benefit will not follow." It is time to start investing in research that will have more impact on society, he adds.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.